邹国荣 - AI Profile | 人才画像

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 60 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long‐term Survival Outcomes and Immune Checkpoint Inhibitor Retreatment in Patients with Advanced Cervical Cancer Treated with Camrelizumab Plus Apatinib in the Phase II CLAP Study

Chunyan Lan,Huaiwu Lu, Lin Zhou, Kunlun Liao,Junxiu Liu, Zhiwen Xie,Haixi Liang,Guorong Zou, Ting Yang,Qin Xu,Xin Huang

CANCER COMMUNICATIONSno. 6 (2024): 654-669

引用0浏览0WOS引用

Abstract PO3-05-10: Efficacy and safety of eribulin plus gemcitabine in second-line or beyond for patients with HER2-negative metastatic breast cancer (MBC): A multi-center, open-label, single-arm, phase II study

PeiJian Peng, Xiao-Lu Xu,Jin-Cai Zhong,Jin-Hui Ye, Zhi-Hui Wang, Hong Wang, Hong Lin,Cai-Wen Du,Guorong Zou, Jie Ouyang, Ying-Ying Shi, Fei Xu,Geng-Sheng Yu,Yong-Kui Lu, Yong-Xia Wang,Shi-En Cui,Lu-Zhen Li

Cancer Researchno. 9_Supplement (2024): PO3-05

引用0浏览0引用

Efficiency and Toxicity of Nab-Paclitaxel and Camrelizumab in the Second or above Line Treatment of Advanced Non-Small Cell Lung Cancer: a Retrospective Cohort Study

Chen Yin,Guo-Rong Zou,Yan He,Juan Li,Hao-Wen Yan,Zhen Su,Xiao-Long Cao,Xiao-Bing Li

Journal of Thoracic Disease（2023）

引用1浏览0WOS引用

Treating Radiation-Related Nasopharyngeal Necrosis with Endostar in Patient with Nasopharyngeal Carcinoma: A Report of Two Cases and a Literature Review

Jie Tang,Xiu-Wen Li,Yong Wu,Zhen Su,Yan He, Xue-Wen Sun,Xiao-Long Cao, Yi-Hua Li,Bi-Cheng Wang,Guo-Rong Zou

MOLECULAR AND CLINICAL ONCOLOGY（2023）

引用0浏览0引用

Efficacy and Safety of Eribulin Plus Gemcitabine in Second-Line or Beyond for Patients with HER2-negative Metastatic Breast Cancer: A Multi-Center, Open-Label, Single-Arm, Phase II Study

Peijian Peng, Xiaolu Xu,Jincai Zhong,Jin-Hui Ye,Zhi-Hui Wang, Hong Wang, Hong Lin,Caiwen Du,Guorong Zou, Jie Ouyang, Ying-ying Shi,Fei Xu,Gengsheng Yu,Yongkui Lu, Yong-Xia Wang,Shi-En Cui,Lu-Zhen Li

Journal of Clinical Oncologyno. 16_suppl (2023): e13102-e13102

引用0浏览0引用

Abstract OT3-25-02: Inetetamab combined with pyrotinib and Chemotherapy in Pretreated Patients with HER2-positive metastatic breast cancer, a single arm, multicenter phase II clinical trial

Jianli Zhao,Yangyang Cai,Linxiaoxiao Ding,Yaping Yang,Guorong Zou,Herui Yao,Ying Wang

Cancer Researchno. 5_Supplement (2023): OT3-25

引用0浏览0引用

Efficacy and safety of sintilimab plus albumin-bound- paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial

Yin Wang, Jing Zhao,Haixi Liang,Junxiu Liu,Shenjiao Huang,Guorong Zou,Xin Huang,Chunyan Lan

ECLINICALMEDICINE (2023): 102274-102274

引用0浏览0WOS引用

Inetetamab Combined with Pyrotinib and Chemotherapy in Pretreated Patients with HER2-positive Metastatic Breast Cancer, a Single Arm, Multicenter Phase II Clinical Trial

Jianli Zhao,Yangyang Cai,Linxiaoxiao Ding,Yaping Yang,Guorong Zou,Herui Yao,Ying Wang

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

GuoRong Zou(邹国荣)

论文共 60 篇作者统计合作学者相似作者